Clinical trial
Comparison of Shenqu Xiaoshi Oral Liquid and Domperidone Suspension in the Treatment of Functional Dyspepsia in Children: a Randomized, Double-blind, Double-simulated, Multi-center Clinical Study
NCT05030116 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Shenqu Xiaoshi Oral Liquid and Domperidone Suspension in the Treatment of Functional Dyspepsia in Children: a Randomized, Double-blind, Double-simulated, Multi-center Clinical Study
- Lead sponsor
- Ruijin Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 26, 2019
- Completion date
- May 23, 2020
- Enrollment
- 356 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.